Lyrica (pregabalin) is not a benzodiazepine. It belongs to a completely different drug class called gabapentinoids, and it is officially classified as an anticonvulsant. The confusion is understandable: Lyrica and benzodiazepines can produce overlapping effects like sedation and anxiety relief, and both carry some risk of dependence. But the two drugs work through entirely different mechanisms in the brain.
How Lyrica Works vs. Benzodiazepines
Benzodiazepines like Xanax, Valium, and Ativan work by enhancing the effect of GABA, the brain’s main calming neurotransmitter. They bind to a specific site on GABA receptors and make those receptors more sensitive to GABA, which increases the flow of chloride ions into nerve cells. This dampens neural signaling broadly across the brain, producing sedation, muscle relaxation, and anxiety relief.
Lyrica takes a fundamentally different route. Although it was originally designed as a synthetic version of GABA, research has shown it has no meaningful effect on GABA receptors at all. Instead, pregabalin binds to a specific protein on voltage-gated calcium channels in the nervous system. By attaching to this protein (called the alpha-2-delta-1 subunit), it reduces the number of calcium channels available at nerve endings. Fewer active calcium channels means less release of excitatory chemical signals between nerves, which dials down pain signaling and overactive nerve firing.
In short, benzodiazepines boost the brain’s braking system directly, while Lyrica reduces the signals that would need braking in the first place. This distinction matters because it affects the drug’s risk profile, side effects, and how the body responds when you stop taking it.
Why People Confuse Them
Several factors blur the line between Lyrica and benzos in people’s minds. Both can cause dizziness, drowsiness, and a feeling of relaxation. Both are used to treat anxiety in some settings. And both carry warnings about dependence and withdrawal.
Lyrica is also a federally controlled substance. The DEA placed pregabalin in Schedule V of the Controlled Substances Act in 2005, classifying it specifically as a depressant. Schedule V is the lowest level of control, well below benzodiazepines, which sit in Schedule IV. Still, the fact that Lyrica is scheduled at all signals that it has some potential for misuse, which adds to the perception that it might be “like a benzo.”
The FDA has also warned that combining Lyrica with opioids, benzodiazepines, or other central nervous system depressants can cause serious breathing problems. Symptoms to watch for include extreme sleepiness, slowed or shallow breathing, confusion, and bluish skin on the lips or fingertips. This shared risk with benzos further contributes to the association.
Lyrica for Anxiety: An Alternative, Not a Substitute
One reason Lyrica gets compared to benzos is its use in treating anxiety. While the FDA has not approved Lyrica for generalized anxiety disorder in the United States, it is approved for this purpose in Europe, and doctors sometimes prescribe it off-label for anxiety in the U.S.
Clinical trial data supports its effectiveness. In pooled analyses of randomized controlled trials, pregabalin showed an effect size of 0.50 for anxiety, compared to 0.38 for benzodiazepines, 0.42 for SNRIs, and 0.36 for SSRIs. It also appears to work relatively quickly, with some evidence of anxiety relief within a few hours before surgical procedures.
A key advantage over benzodiazepines is what happens when you stop. Studies comparing pregabalin to lorazepam (a common benzo) found significantly fewer withdrawal symptoms after discontinuing pregabalin. Some clinicians have even used pregabalin to help patients taper off long-term benzodiazepine use, with roughly half of patients in one study successfully becoming benzo-free over 12 weeks while using pregabalin as a bridge.
What Lyrica Is Approved to Treat
Lyrica has five FDA-approved uses, most of them related to nerve pain:
- Nerve pain from diabetic neuropathy
- Nerve pain after shingles (postherpetic neuralgia)
- Nerve pain from spinal cord injury
- Fibromyalgia
- Partial-onset seizures in adults (as an add-on treatment)
None of these overlap with typical benzodiazepine prescriptions, which center on anxiety disorders, insomnia, muscle spasms, and seizure emergencies. The approved uses reflect Lyrica’s core strength: calming overactive nerve signaling rather than broadly sedating the brain.
Withdrawal and Dependence Risk
Like benzodiazepines, Lyrica can cause physical dependence, and stopping abruptly can trigger withdrawal symptoms. These include insomnia, anxiety, nausea, headache, sweating, diarrhea, and restlessness. In more severe cases reported in the medical literature, withdrawal has involved tremors, hallucinations, rapid heart rate, and even seizures.
What makes Lyrica withdrawal noteworthy is that it can occur even at standard prescribed doses after relatively short periods of use. This is not unique to people taking high doses or misusing the drug. Gradual tapering is the standard recommendation for anyone discontinuing pregabalin, regardless of how long they have been on it.
The withdrawal profile shares some features with benzodiazepine withdrawal, particularly the rebound anxiety and insomnia. This similarity is another reason people mentally group the two drugs together. However, benzodiazepine withdrawal is generally considered more dangerous and protracted, especially after long-term use at higher doses, and carries a well-documented risk of life-threatening seizures that is less established with pregabalin.
Common Side Effects
The most frequently reported side effects of Lyrica are dizziness and drowsiness, which also happen to be the most common benzodiazepine side effects. Beyond those shared effects, Lyrica is more likely to cause weight gain, blurred vision, dry mouth, and swelling in the hands and feet. Benzodiazepines are more strongly associated with problems like memory impairment, poor coordination, and significant cognitive slowing.
When pregabalin and benzodiazepines have been compared head-to-head in anxiety studies, pregabalin was more likely to cause dizziness, while benzodiazepines were more likely to cause drowsiness and coordination problems. Both can impair your ability to drive or operate machinery, particularly when you first start taking them or after a dose increase.